Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:23:32.522Z.
Calculation as of: 2026-10-06T18:23:32.522Z.
Quote observation: 2026-10-06T18:07:43.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 967c3c4e1026402272b5761d24a9cd8122a999a0fe4ad26a1d84866f163ab752
EARNINGS YIELD
N/A
Market Cap
$59.03M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$62.85M
Earnings Yield
N/A
TTM Avg
2.54%
3Y Avg
2.54%
5Y Avg
2.54%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xilio Therapeutics, Inc. (XLO) | $60.89M | N/A | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $60.68M | N/A | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $61.67M | N/A | N/A | N/A | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | N/A | N/A | N/A | N/A |
| Adicet Bio, Inc. (ACET)vs › | $59.78M | N/A | 0.93% | 0.93% | 0.93% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $59.03M | N/A | N/A | N/A | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $62.85M | N/A | 2.54% | 2.54% | 2.54% |
| RenovoRx, Inc. (RNXT)vs › | $63.07M | N/A | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $63.25M | N/A | N/A | N/A | N/A |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.41M | N/A | 34.60% | 34.60% | 34.60% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
